Management of Edema and Proteinuria

Initial Evaluation

The American Journal of Kidney Diseases recommends measuring blood pressure with standard clinic measurements and determining a target systolic blood pressure of <120 mmHg in patients with edema and proteinuria 1, 3
Quantification of proteinuria using the urine albumin-to-creatinine ratio or 24-hour urine protein is necessary to determine the severity of the condition 1
Assessment of kidney function (eGFR and serum creatinine) is crucial to determine the appropriate therapy strategy 1, 4
Urine sediment evaluation is necessary to look for signs of active glomerular disease 5

The Kidney International guidelines recommend starting ACE inhibitors or ARBs and titrating up to the maximum tolerated dose, not just the dose that achieves blood pressure targets 1, 2
Uptitration of ACEi/ARB to the maximum dose is recommended even if blood pressure is already controlled, as the antiproteinuric effect is not entirely dependent on blood pressure reduction 1, 3
The American Journal of Kidney Diseases suggests not stopping ACEi/ARB if there is a moderate and stable increase in serum creatinine (up to 30%), unless kidney function continues to deteriorate or refractory hyperkalemia occurs 6, 3

The Kidney International guidelines recommend using diuretics to manage edema, with the choice of diuretic class based on the severity of the edema 1, 5
Thiazide diuretics are recommended for mild edema with eGFR >30 ml/min/1.73 m², while loop diuretics are recommended for moderate to severe edema or if eGFR <30 ml/min/1.73 m² 1, 5
Combination diuretics (loop + thiazide or loop + mineralocorticoid receptor antagonist) may be used for refractory edema 1, 5

The Kidney International guidelines recommend restricting dietary sodium to <2.0 g/day (<90 mmol/day) for all patients with proteinuria and edema 1, 2, 3
Further sodium restriction may be necessary for patients who fail to achieve a reduction in proteinuria with medical therapy 1, 2

The American Journal of Kidney Diseases suggests considering immunosuppressive therapy if proteinuria persists >1 g/day after 3-6 months of optimal supportive therapy (ACEi/ARB at maximum dose, blood pressure control, sodium restriction) 4, 7, 2
For IgA nephropathy, corticosteroids for 6 months may be considered if proteinuria persists >1 g/day and eGFR >50 ml/min/1.73 m² 4, 7, 2

The Kidney International guidelines recommend monitoring laboratory tests (serum creatinine, potassium, and proteinuria) regularly 1, 3
The American Journal of Kidney Diseases suggests that improvement in proteinuria should be seen within 3 months, with a minimum reduction of 50% in 6 months 3
If there is no response after 6 months of optimal therapy, consideration of kidney biopsy (if not already done) or immunosuppressive therapy may be necessary 4, 6, 2